[{"id":"186c2337-e818-4472-b305-dbb1faa1e180","acronym":"","url":"https://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml?id=217d0246135242709c655af51190a145","created_at":"2026-06-27T03:47:21.415Z","updated_at":"2026-06-27T03:47:21.415Z","phase":"Phase 2","brief_title":"A study of TAK-788 in the treatment of metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations.","source_id_and_acronym":"CTR20190582","lead_sponsor":"Millennium Pharmaceuticals, Inc. / Mayne Pharma Inc. / Takeda Pharmaceutical (China) Co., Ltd.","biomarkers":" HER-2","pipe":" | ","alterations":" EGFR mutation • HER-2 mutation • EGFR exon 20 insertion • EGFR A763_Y764insFQEA • EGFR exon 20 mutation","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • HER-2 mutation • EGFR exon 20 insertion • EGFR A763_Y764insFQEA • EGFR exon 20 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Exkivity (mobocertinib)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 07/15/2019","start_date":" 07/15/2019","primary_txt":"","primary_completion_date":"","study_txt":"","study_completion_date":"","last_update_posted":"2026-06-24"},{"id":"00bd8728-3f59-46ec-9a86-63c1172937ee","acronym":"","url":"https://clinicaltrials.gov/study/NCT03807778","created_at":"2021-01-18T18:49:03.389Z","updated_at":"2024-07-02T16:35:14.426Z","phase":"Phase 1","brief_title":"A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT03807778","lead_sponsor":"Takeda","biomarkers":" EGFR • HER-2","pipe":" | ","alterations":" EGFR L858R • HER-2 mutation • EGFR exon 19 deletion • EGFR exon 20 insertion • EGFR A763_Y764insFQEA • EGFR exon 20 mutation","tags":["EGFR • HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR L858R • HER-2 mutation • EGFR exon 19 deletion • EGFR exon 20 insertion • EGFR A763_Y764insFQEA • EGFR exon 20 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Exkivity (mobocertinib)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 53","initiation":"Initiation: 02/04/2019","start_date":" 02/04/2019","primary_txt":" Primary completion: 11/08/2021","primary_completion_date":" 11/08/2021","study_txt":" Completion: 03/31/2025","study_completion_date":" 03/31/2025","last_update_posted":"2024-03-15"}]